BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9242374)

  • 21. Retinoblastoma protein recruits histone deacetylase to repress transcription.
    Brehm A; Miska EA; McCance DJ; Reid JL; Bannister AJ; Kouzarides T
    Nature; 1998 Feb; 391(6667):597-601. PubMed ID: 9468139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S; Nath N; Adlam M; Chellappan S
    Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a yeast transcription factor IID subunit, TSG2/TAF48.
    Reese JC; Zhang Z; Kurpad H
    J Biol Chem; 2000 Jun; 275(23):17391-8. PubMed ID: 10751405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCG1/TAF(II)250 regulates epidermal growth factor receptor gene transcription in cell cycle mutant ts13.
    Vargas GA; Isas JM; Fantino E; Gargus JJ; Haigler HT
    J Cell Physiol; 1998 Sep; 176(3):642-7. PubMed ID: 9699517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Jun binds the N terminus of human TAF(II)250 to derepress RNA polymerase II transcription in vitro.
    Lively TN; Ferguson HA; Galasinski SK; Seto AG; Goodrich JA
    J Biol Chem; 2001 Jul; 276(27):25582-8. PubMed ID: 11316804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rb inhibits the intrinsic kinase activity of TATA-binding protein-associated factor TAFII250.
    Siegert JL; Robbins PD
    Mol Cell Biol; 1999 Jan; 19(1):846-54. PubMed ID: 9858607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of CIA/ASF1 as an interactor of bromodomains associated with TFIID.
    Chimura T; Kuzuhara T; Horikoshi M
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9334-9. PubMed ID: 12093919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein-associated factor TAFII250.
    Shao Z; Ruppert S; Robbins PD
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3115-9. PubMed ID: 7724524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif.
    Chow KN; Dean DC
    Mol Cell Biol; 1996 Sep; 16(9):4862-8. PubMed ID: 8756645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s.
    Frontini M; Imbriano C; diSilvio A; Bell B; Bogni A; Romier C; Moras D; Tora L; Davidson I; Mantovani R
    J Biol Chem; 2002 Feb; 277(8):5841-8. PubMed ID: 11689552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear localization conferred by the pocket domain of the retinoblastoma gene product.
    Zacksenhaus E; Jiang Z; Hei YJ; Phillips RA; Gallie BL
    Biochim Biophys Acta; 1999 Sep; 1451(2-3):288-96. PubMed ID: 10556583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-type-specific expression of the TFIID component TAF(II)135 in the nervous system.
    Metsis M; Brunkhorst A; Neuman T
    Exp Cell Res; 2001 Oct; 269(2):214-21. PubMed ID: 11570813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proposed interaction between insulin and retinoblastoma protein.
    Radulescu RT; Wendtner CM
    J Mol Recognit; 1992 Dec; 5(4):132-7. PubMed ID: 1339481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-cycle-dependent phosphorylation of the basal transcription factor RAP74.
    Yonaha M; Tsuchiya T; Yasukochi Y
    FEBS Lett; 1997 Jun; 410(2-3):477-80. PubMed ID: 9237686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and functional characterization of the acidic region from the RIZ tumor suppressor.
    Sun Y; Stine JM; Atwater DZ; Sharmin A; Ross JB; Briknarová K
    Biochemistry; 2015 Feb; 54(6):1390-400. PubMed ID: 25640033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retraction. TAF(II)s mediate activation of transcription in the Drosophila embryo.
    Sauer F; Wassarman DA; Rubin GM; Tjian R
    Cell; 1998 Nov; 95(4):following 573. PubMed ID: 9867425
    [No Abstract]   [Full Text] [Related]  

  • 37. [STUDIES ON THE FUNCTION OF CONCENTRATION MAINTENANCE (TAF). DISCUSSION ON THREE-MINUTE METHOD OF THE TAF-TEST].
    MATSUI K; SAKAMOTO H; KOJIMA T
    Nihon Eiseigaku Zasshi; 1965 Apr; 20():26-33. PubMed ID: 14328094
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting
    Linn P; Kohno S; Sheng J; Kulathunga N; Yu H; Zhang Z; Voon D; Watanabe Y; Takahashi C
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer.
    Brough R; Gulati A; Haider S; Kumar R; Campbell J; Knudsen E; Pettitt SJ; Ryan CJ; Lord CJ
    Oncogene; 2018 Oct; 37(43):5701-5718. PubMed ID: 29915391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural insights into the mechanism of phosphoregulation of the retinoblastoma protein.
    Lamber EP; Beuron F; Morris EP; Svergun DI; Mittnacht S
    PLoS One; 2013; 8(3):e58463. PubMed ID: 23516486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.